Annotation Detail

Information
Associated Genes
PTEN
Associated Variants
PTEN DELETION ( ENST00000371953.8 )
PTEN DELETION ( ENST00000371953.8 )
Associated Disease
cancer
Source Database
CIViC Evidence
Description
All three patients with PTEN loss had benefit from adding Buparlisib to carboplatin+paclitaxel therapy in a phase I study in advanced solid cancers.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/714
Gene URL
https://civic.genome.wustl.edu/links/genes/41
Variant URL
https://civic.genome.wustl.edu/links/variants/214
Rating
3
Evidence Type
Predictive
Disease
Cancer
Evidence Direction
Supports
Drug
Paclitaxel,Carboplatin,Buparlisib
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
25672916
Drugs
Drug NameSensitivitySupported
BuparlisibSensitivitytrue
CarboplatinSensitivitytrue
PaclitaxelSensitivitytrue